Almost $1 billion invested in cord blood research last year

Over $938 million was invested in using cord blood stem cells to treat a whole host of illnesses and conditions in the US last year.

Researchers are confident that these non-controversial stem cells will make a significant difference to the way that diseases and illnesses are treated in the future. Current research shows that stem cells may play a part in the treatment of degenerative diseases and conditions such as Parkinson’s Disease, Muscular Dystrophy, Alzheimers, strokes, heart and liver disease. Thousands of New Zealand parents have recognised this once in a lifetime opportunity and have chosen to bank their baby’s cord blood with CordBank giving their children the chance to benefit should they face these diseases in later life.